Rollman, J. E., Heyward, J., Olson, L., Lurie, P., Sharfstein, J., & Alexander, G. C. (2019). Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products. JAMA.
Citação norma ChicagoRollman, Jeffrey Eric, James Heyward, Lily Olson, Peter Lurie, Joshua Sharfstein, and G. Caleb Alexander. "Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products." JAMA 2019.
Citação norma MLARollman, Jeffrey Eric, et al. "Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products." JAMA 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.